- Home
- CNTB vs TTOO Comparison
CNTB vs TTOO Comparison
Compare CNTB & TTOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTB
- TTOO
- Stock Information
- Founded
- CNTB 2012
- TTOO 2006
- Country
- CNTB United States
- TTOO United States
- Employees
- CNTB N/A
- TTOO N/A
- Industry
- CNTB Biotechnology: Pharmaceutical Preparations
- TTOO Medical/Dental Instruments
- Sector
- CNTB Health Care
- TTOO Health Care
- Exchange
- CNTB Nasdaq
- TTOO Nasdaq
- Market Cap
- CNTB 68.5M
- TTOO 36.4M
- IPO Year
- CNTB 2021
- TTOO 2014
- Fundamental
- Price
- CNTB $1.17
- TTOO $0.97
- Analyst Decision
- CNTB Strong Buy
- TTOO Hold
- Analyst Count
- CNTB 1
- TTOO 1
- Target Price
- CNTB $8.00
- TTOO $5.00
- AVG Volume (30 Days)
- CNTB 24.6K
- TTOO 710.5K
- Earning Date
- CNTB 09-05-2024
- TTOO 11-13-2024
- Dividend Yield
- CNTB N/A
- TTOO N/A
- EPS Growth
- CNTB N/A
- TTOO N/A
- EPS
- CNTB N/A
- TTOO N/A
- Revenue
- CNTB $24,116,000.00
- TTOO $7,164,000.00
- Revenue This Year
- CNTB N/A
- TTOO $50.31
- Revenue Next Year
- CNTB $63.90
- TTOO $117.92
- P/E Ratio
- CNTB N/A
- TTOO N/A
- Revenue Growth
- CNTB N/A
- TTOO N/A
- 52 Week Low
- CNTB $0.68
- TTOO $0.90
- 52 Week High
- CNTB $2.84
- TTOO $8.38
- Technical
- Relative Strength Index (RSI)
- CNTB 44.02
- TTOO 18.34
- Support Level
- CNTB $1.18
- TTOO $0.90
- Resistance Level
- CNTB $1.26
- TTOO $1.86
- Average True Range (ATR)
- CNTB 0.07
- TTOO 0.15
- MACD
- CNTB -0.01
- TTOO -0.00
- Stochastic Oscillator
- CNTB 13.59
- TTOO 5.72
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
About TTOO T2 Biosystems Inc.
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.